R&D
Sponsored
Best practices in cardiometabolic trial design: Planning and...
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
R&D
Whole-genome sequencing in the UK and Europe, with Mark Robi...
Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
News
Madrigal builds in MASH with $4.4bn+ Ribo alliance
Already sitting on a blockbuster therapy for MASH, Madrigal has beefed up its pipeline with six siRNA candidates licensed from China's Ribo.
News
UK moves ahead with GP patient data sharing plan
The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.
News
Kailera, Hengrui stake claim to oral weight loss category
Chasing Novo Nordisk and Eli Lilly, Kailera and Hengrui have reported 12.1% weight loss in phase 2 with their oral GIP/GLP-1 agonist ribupatide.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
